Status: current, Defined. Date: 31-May 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4081661000168116 | Xeljanz (tofacitinib 5 mg) tablet, 180 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4081671000168110 | Xeljanz 5 mg tablet, 180, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xeljanz 5 mg tablet, 180, bottle | Is a | Xeljanz 5 mg tablet, 180 | true | Inferred relationship | Some | ||
| Xeljanz 5 mg tablet, 180, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Xeljanz 5 mg tablet, 180, bottle | has TPUU | Xeljanz 5 mg tablet | true | Inferred relationship | Some | 1 | |
| Xeljanz 5 mg tablet, 180, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Xeljanz 5 mg tablet, 180, bottle | has TP | Xeljanz | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Black Triangle Scheme reference set
Containered trade product pack reference set
FHIR